- 专利标题： ANTI-TRANSTHYRETIN ANTIBODIES
-
申请号： US16789319申请日： 2020-02-12
-
公开(公告)号： US20200277361A1公开(公告)日： 2020-09-03
- 发明人: Tarlochan S. Nijjar , Avijit Chakrabartty , Jeffrey N. Higaki
- 申请人： PROTHENA BIOSCIENCES LIMITED , UNIVERSITY HEALTH NETWORK
- 申请人地址： IE Dublin 2 CA Toronto
- 专利权人： PROTHENA BIOSCIENCES LIMITED,UNIVERSITY HEALTH NETWORK
- 当前专利权人： PROTHENA BIOSCIENCES LIMITED,UNIVERSITY HEALTH NETWORK
- 当前专利权人地址： IE Dublin 2 CA Toronto
- 主分类号： C07K16/18
- IPC分类号： C07K16/18 ; G01N33/68
摘要：
The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.
公开/授权文献
- US11267878B2 Anti-transthyretin antibodies 公开/授权日：2022-03-08
信息查询
